One woman’s journey from receiving her diagnosis to finding a treatment that helps manage her chronic skin condition.

It is approved for use in rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and adults with chronic moderate-to-severe plaque psoriasis. In clinical ...

particularly when the disease takes a severe, chronic course. The typical skin change (primary lesion) of psoriasis is a sharply demarcated erythrosquamous plaque; it appears infiltrated and ...

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritis Two trials for active psoriatic arthritis (PsA) with one focusing on ...

Generally speaking, PASI is used for moderate to severe cases of plaque psoriasis and when you're treated with biologic ... Your healthcare provider will identify this chronic condition by reviewing ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

Medically reviewed by Doru Paul, MD To confirm a psoriasis diagnosis, your healthcare provider will check your skin and scalp ...

Several types of psoriasis may affect your arms, but plaque psoriasis is the most ... You'll have flare-ups with mild to severe skin symptoms and periods of remission. Since psoriasis is a chronic, ...

"The approval of Sotyktu represents an exciting day for patients suffering from moderate-to-severe plaque psoriasis who are ... extending its use into other chronic inflammatory diseases like ...

Organon is a strong investment opportunity with a high yield, diversified portfolio, steady performance, and transformative ...